Top Markets
Coin of the day
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Classifica tra le azioni #19834
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Prezzo delle azioni
$9.61
Ultima sincronizzazione: 2026-08-25
Capitalizzazione di mercato
$149.33M
Variazione (1 giorno)
-1.39%
Variazione (1 anno)
21.24%
Paese
US
Scambia Alpha Cognition Inc (ACOG)

Categoria

Storico del prezzo dell'azione per Alpha Cognition Inc (ACOG)
Prezzo di chiusura più alto: $9.07 il 2026-08-01

Prezzo di chiusura più basso: $6.45 il 2024-11-01
Storico del prezzo dell'azione di Alpha Cognition Inc dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 13.45%
2025 7.90%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$123.07 -11.95%
AU
$772.27 7.33%
CH